Ingenium publishes biological characterization of first mouse model for kidney stones

Ingenium Pharmaceuticals AG announced today the publication in the journal Human Molecular Genetics of the first mouse model for cystinuria type I, a disease commonly known as kidney stones. The mouse mimics the clinical manifestations of the human disease and represents a novel model for researching therapeutic approaches.

"The Human Molecular Genetics publication describes a prime example of an INGENOtypes model: biologically well-characterized and an improvement over current models because it is the result of single base pair substitutions in the gene, which produces a phenotype closely representing a human disease state," stated Michael C. Nehls, M.D., Ph.D., Chief Executive Officer at Ingenium. "The publication underscores the value of our models for biomedical research in the areas of disease analysis and drug compound and therapeutic hypotheses testing."

As described in the publication, the mouse model was identified as part of Ingenium's Deductive GenomicsTM research, which involves a screen for medically relevant phenotypes in a third generation of mice treated with ENU, a chemical process that generates point mutations in genes. This specific model was located due to raised levels of urea in the blood, a hallmark of impaired renal function.

Further research located multiple similarities with the human disease cystinuria type I including the presence of relatively large calculi or "stones" in the urinary tract of the animal. Ingenium researchers located the mutation responsible for the disease state in the Slc3a1 gene. Mutations in the human Slc3a1 gene have long been associated with cystinuria, demonstrating a direct link and further validation of the mouse as a model for cystinuria type I disease research.

"The goal of our research is to better understand the molecular pathway involved with cystinuria type I and this model is a welcome addition because it is the first model that so closely mimics the

Contact: Gretchen Schweitzer
Ingenium Pharmaceuticals

Page: 1 2

Related biology news :

1. Ingenium publishes groundbreaking research on genetic basis for motor neuron degeneration
2. Wiley publishes Welcome to the Genome: A Users Guide to the Genetic Past, Present, and Future
3. Warren Pharmaceuticals publishes results of preclinical evaluation
4. Professor publishes book on historic mosquito wars
5. AGI publishes 42nd edition of Directory of Geoscience Departments
6. International HapMap Consortium publishes scientific strategy
7. OHSU researcher publishes first measurements of free-base nicotine in cigarette smoke
8. AGI publishes 41st edition of Directory of Geoscience Departments
9. USDA Forest Service publishes wildland-urban interface assessment
10. Mitokor publishes human mitochondrial genome sequencing study - American Journal of Human Genetics
11. Cellzome publishes novel approach for the systematic use of protein interaction maps in drug discovery in Nature

Post Your Comments:

(Date:8/26/2020)... ... August 25, 2020 , ... Catalent, the leading global provider ... gene therapies, and consumer health products, today announced that two Catalent Biologics experts ... taking place between Aug. 31 – September 4, 2020. , On Wednesday, Sept. ...
(Date:8/21/2020)... (PRWEB) , ... August 19, 2020 , ... ... Salimetrics LLC and SalivaBio LLC, businesses dedicated to Salivary Bioscience for more than ... the recently published book by Springer, " Salivary Bioscience: Foundations of Interdisciplinary Saliva ...
(Date:8/12/2020)... (PRWEB) , ... August 12, 2020 , ... ... and monitoring systems that are ideal for public health agencies of all sizes. ... contagious diseases and helping at-risk individuals find appropriate health care, Mosio helps public ...
Breaking Biology News(10 mins):
(Date:8/15/2020)... ... August 13, 2020 , ... Inc. magazine today revealed ... prestigious ranking of the nation’s fastest-growing private companies. The list represents a unique ... independent small businesses. Intuit, Zappos, Under Armour, Microsoft, Patagonia, and many other well-known ...
(Date:8/12/2020)... ... August 11, 2020 , ... ... making available for free its new white paper – Simulated Transport Methodologies. ... into today’s biologics licensing application (BLA). In response, Modality Solutions shares an ...
(Date:8/7/2020)... ... 06, 2020 , ... VGXI, a highly regarded CDMO supporting ... purchase of greenfield for a new, expanded manufacturing facility. The site is located ... the initial acquisition, with an option to purchase an additional 21 acres for ...
(Date:8/3/2020)... ... ... Introducing Ardent Animal Health – MediVet Biologics rebrands company and positions its platform ... Biologics since its formation in 2016, the company is relaunching itself under the Ardent ... its base of innovative therapies for osteoarthritis and cancer. , ...
Breaking Biology Technology:
Cached News: